Guiyang Xintian Pharmaceutical Co Ltd (002873) — Strategic Asset Allocation Index
Guiyang Xintian Pharmaceutical Co Ltd (002873) has a Strategic Asset Allocation Index of 54.5% as of September 2023. Strategic assets (PP&E of CN¥651.18 Million plus long-term investments of CN¥-) total CN¥651.18 Million, measured against net assets of CN¥1.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002873 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Guiyang Xintian Pharmaceutical Co Ltd Strategic Asset Allocation Index (2015–2021)
This chart shows how Guiyang Xintian Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of September 2023, the index stands at 54.5%, representing strategic assets of CN¥651.18 Million against net assets of CN¥1.20 Billion CNY. See Guiyang Xintian Pharmaceutical Co Ltd (002873) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Guiyang Xintian Pharmaceutical Co Ltd (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guiyang Xintian Pharmaceutical Co Ltd from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002873 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 52.1% | CN¥463.94 Million | CN¥463.94 Million | CN¥- | CN¥890.44 Million | ▲ +6.1 pp |
| 2020 | 46.0% | CN¥381.09 Million | CN¥381.09 Million | CN¥- | CN¥828.30 Million | ▼ -4.3 pp |
| 2019 | 50.3% | CN¥356.57 Million | CN¥356.57 Million | CN¥- | CN¥708.76 Million | ▲ +12.4 pp |
| 2018 | 37.9% | CN¥250.56 Million | CN¥250.56 Million | CN¥- | CN¥660.59 Million | ▼ -2.0 pp |
| 2017 | 39.9% | CN¥248.19 Million | CN¥248.19 Million | CN¥- | CN¥622.11 Million | ▼ -17.3 pp |
| 2016 | 57.2% | CN¥159.83 Million | CN¥159.83 Million | CN¥- | CN¥279.21 Million | ▼ -16.2 pp |
| 2015 | 73.4% | CN¥166.17 Million | CN¥166.17 Million | CN¥- | CN¥226.31 Million | — |